BlueCrest Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-46,764	Closed	-$1.76M	–	788
2017 Q3	$1.76M	Buy	+46,764	New	+$1.76M	0.07%	260
2017 Q2	–	Sell	-9,424	Closed	-$324K	–	861
2017 Q1	$324K	Buy	+9,424	New	+$324K	0.02%	489